CW Advisors LLC Raises Position in CVS Health Corporation $CVS

CW Advisors LLC increased its position in shares of CVS Health Corporation (NYSE:CVS) by 27.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 247,450 shares of the pharmacy operator’s stock after purchasing an additional 52,644 shares during the quarter. CW Advisors LLC’s holdings in CVS Health were worth $17,069,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. FineMark National Bank & Trust boosted its position in CVS Health by 1.7% in the second quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after purchasing an additional 157 shares during the last quarter. Hazlett Burt & Watson Inc. grew its position in CVS Health by 10.9% during the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock valued at $117,000 after buying an additional 165 shares during the period. Loomis Sayles & Co. L P increased its holdings in CVS Health by 11.0% during the second quarter. Loomis Sayles & Co. L P now owns 1,674 shares of the pharmacy operator’s stock worth $115,000 after buying an additional 166 shares during the last quarter. Williams Financial LLC raised its position in CVS Health by 2.5% in the second quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after acquiring an additional 167 shares during the period. Finally, Hemington Wealth Management boosted its stake in CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 172 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $75.15 on Thursday. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The stock’s 50-day simple moving average is $78.71 and its 200 day simple moving average is $71.11. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock has a market capitalization of $95.39 billion, a price-to-earnings ratio of 197.76, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same period in the prior year, the business posted $1.09 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Mizuho raised their price target on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Piper Sandler boosted their target price on CVS Health from $81.00 to $99.00 in a research note on Friday, October 31st. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Argus boosted their price objective on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Finally, Cantor Fitzgerald increased their target price on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $90.52.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.